1. Home
  2. CCRN vs OMER Comparison

CCRN vs OMER Comparison

Compare CCRN & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRN
  • OMER
  • Stock Information
  • Founded
  • CCRN 1986
  • OMER 1994
  • Country
  • CCRN United States
  • OMER United States
  • Employees
  • CCRN N/A
  • OMER N/A
  • Industry
  • CCRN Professional Services
  • OMER Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCRN Consumer Discretionary
  • OMER Health Care
  • Exchange
  • CCRN Nasdaq
  • OMER Nasdaq
  • Market Cap
  • CCRN 447.2M
  • OMER 513.8M
  • IPO Year
  • CCRN N/A
  • OMER 2009
  • Fundamental
  • Price
  • CCRN $12.75
  • OMER $7.80
  • Analyst Decision
  • CCRN Hold
  • OMER Strong Buy
  • Analyst Count
  • CCRN 5
  • OMER 6
  • Target Price
  • CCRN $17.93
  • OMER $27.50
  • AVG Volume (30 Days)
  • CCRN 296.6K
  • OMER 8.2M
  • Earning Date
  • CCRN 11-05-2025
  • OMER 11-12-2025
  • Dividend Yield
  • CCRN N/A
  • OMER N/A
  • EPS Growth
  • CCRN N/A
  • OMER N/A
  • EPS
  • CCRN N/A
  • OMER N/A
  • Revenue
  • CCRN $1,192,539,000.00
  • OMER N/A
  • Revenue This Year
  • CCRN N/A
  • OMER N/A
  • Revenue Next Year
  • CCRN N/A
  • OMER N/A
  • P/E Ratio
  • CCRN N/A
  • OMER N/A
  • Revenue Growth
  • CCRN N/A
  • OMER N/A
  • 52 Week Low
  • CCRN $9.58
  • OMER $2.95
  • 52 Week High
  • CCRN $18.33
  • OMER $13.60
  • Technical
  • Relative Strength Index (RSI)
  • CCRN 46.20
  • OMER 63.02
  • Support Level
  • CCRN $12.33
  • OMER $7.44
  • Resistance Level
  • CCRN $13.23
  • OMER $8.05
  • Average True Range (ATR)
  • CCRN 0.52
  • OMER 0.73
  • MACD
  • CCRN -0.01
  • OMER 0.04
  • Stochastic Oscillator
  • CCRN 57.87
  • OMER 47.17

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: